← Back to Search

Other

Oral Dissolvable Tablet Zofran (OZ) for Vomiting (VOMIITED Trial)

Phase < 1
Waitlist Available
Led By Scott Crawford, MD
Research Sponsored by Texas Tech University Health Sciences Center, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients aged 18-65 years presenting to the emergency department complaining of current nausea with or without episodes of emesis beginning within the previous 24hrs
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 minutes
Awards & highlights

VOMIITED Trial Summary

This trial will compare the two methods to see which is more effective.

Eligible Conditions
  • Vomiting
  • Nausea

VOMIITED Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

VOMIITED Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 60 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Nausea Severity
Secondary outcome measures
Emesis Event

VOMIITED Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Oral Dissolvable Tablet Zofran (OZ)Experimental Treatment1 Intervention
4 mg Oral Dissolvable Tablet Zofran (ondansetron)
Group II: Inhaled Isopropyl Alcohol (IPA)Active Control1 Intervention
Inhaled Isopropyl Alcohol (alcohol prep pad)
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Oral Dissolvable Tablet Zofran (ondansetron)
2017
Completed Early Phase 1
~130

Find a Location

Who is running the clinical trial?

Texas Tech University Health Sciences Center, El PasoLead Sponsor
49 Previous Clinical Trials
4,999 Total Patients Enrolled
Scott Crawford, MD5.01 ReviewsPrincipal Investigator - Texas Tech Universtiy Health Sciences Center El Paso
Texas Tech University Health Sciences Center, El Paso

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
American Journal of GastroenterologyJournal
Clinical and Economic Burden of Emergency Department Visits Due to Gastrointestinal Diseases in the United States
Myer, Parvathi A, Ajitha Mannalithara, Gurjot Singh, Gurkirpal Singh, Pankaj J Pasricha, and Uri Ladabaum. 2013. “Clinical and Economic Burden of Emergency Department Visits Due to Gastrointestinal Diseases in the United States”. American Journal of Gastroenterology. Ovid Technologies (Wolters Kluwer Health). doi:10.1038/ajg.2013.199.
The American Journal of Emergency MedicineJournal
Antiemetics in the ED: A Randomized Controlled Trial Comparing 3 Common Agents
Braude, Darren, Tricia Soliz, Cameron Crandall, Greg Hendey, James Andrews, and Lori Weichenthal. 2006. “Antiemetics in the ED: A Randomized Controlled Trial Comparing 3 Common Agents”. The American Journal of Emergency Medicine. Elsevier BV. doi:10.1016/j.ajem.2005.08.017.
The Journal of Emergency MedicineJournal
Antiemetic Therapy for Nausea and Vomiting in the Emergency Department
Patanwala, Asad E., Richard Amini, Daniel P. Hays, and Peter Rosen. 2010. “Antiemetic Therapy for Nausea and Vomiting in the Emergency Department”. The Journal of Emergency Medicine. Elsevier BV. doi:10.1016/j.jemermed.2009.08.060.
The American Journal of Emergency MedicineJournal
A Randomized, Placebo-controlled Trial of Ondansetron, Metoclopramide, and Promethazine in Adults
Barrett, Tyler W., David M. DiPersio, Cathy A. Jenkins, Meg Jack, Nicole Streiff McCoin, Alan B. Storrow, Lori M. Singleton, Patricia Lee, Chuan Zhou, and Corey M. Slovis. 2011. “A Randomized, Placebo-controlled Trial of Ondansetron, Metoclopramide, and Promethazine in Adults”. The American Journal of Emergency Medicine. Elsevier BV. doi:10.1016/j.ajem.2009.09.028.
~16 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top